Provided by Tiger Trade Technology Pte. Ltd.

YieldMax MRNA Option Income Strategy ETF

39.10
+0.24000.62%
Post-market: 38.75-0.3500-0.90%19:55 EDT
Volume:185.81K
Turnover:7.20M
Market Cap:211.33M
PE:- -
High:39.53
Open:39.11
Low:37.67
Close:38.86
52wk High:42.63
52wk Low:13.60
Shares:5.40M
Float Shares:5.40M
Volume Ratio:0.58
T/O Rate:3.44%
Dividend:17.77
Dividend Rate:45.44%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Moderna Inc Stock (MRNA) Moved Up by 14.21% on Sep 21: Drivers Behind the Movement

TradingKey
·
Sep 22

Moderna Stock Jumps. Its mRNA Cancer Vaccine is Getting Ready for Its Next Big Test.

Dow Jones
·
Sep 22

Moderna to Present Late-Breaking Phase 3 Melanoma Data for Intismeran Autogene at ESMO 2026

Reuters
·
Sep 22

S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT

Reuters
·
Sep 22

Moderna announces late-breaking data to be presented at ESMO Congress 2026

TIPRANKS
·
Sep 21

InspireMD Announces Amendments to Certain Series J and Series K Warrants, Providing Potential Gross Proceeds of Up to $11 Million

GlobeNewswire
·
Sep 21

Ultragenyx price target raised to $35 from $32 at Barclays

TIPRANKS
·
Sep 21

Analysts Offer Insights on Healthcare Companies: Moderna (MRNA) and Amneal Pharmaceuticals (AMRX)

TIPRANKS
·
Sep 21

Amneal Pharmaceuticals announces FDA approval and launch of Lanreotide

TIPRANKS
·
Sep 19

Cboe data shows mixed options sentiment in Moderna with shares down 1.49%

TIPRANKS
·
Sep 18

LIVE Markets-Cash-Return Stocks Win Back Investor Favor, Leaving Megacaps Behind

Reuters
·
Sep 18

Abeona Therapeutics ‘congratulated’ Ultragenyx on U.S FDA approval of UX111

TIPRANKS
·
Sep 18

Moderna stock rises 8%: can it continue its cancer vaccine success rally?

Bellwether Stocks Movement
·
Sep 18

Moderna Inc. Stock Climbs 8.5%, Outperforms Peers

Dow Jones
·
Sep 18

Ultragenyx confirms FDA approval of Fayuvi

TIPRANKS
·
Sep 18

S&P 500 Top and Bottom Performing Stocks at About 03:30 P.m. EDT

Reuters
·
Sep 18

Moderna Inc Stock (MRNA) Moved Up by 7.25% on Sep 17: Facts Behind the Movement

TradingKey
·
Sep 18

Moderna: Another Day, Another Big Stock Move. is the Cancer Vaccine Rally Back On?

Dow Jones
·
Sep 18

Moderna Shares Hit Four-Week High; Last up 8%

THOMSON REUTERS
·
Sep 17

Nuvation Bio announces FDA approval of sNDA for Ibtrozi

TIPRANKS
·
Sep 17